NHS Greater Glasgow and Clyde is an NHS board in West Central Scotland, created from the amalgamation of NHS Greater Glasgow and part of NHS Argyll and Clyde on 1 April 2006.

During the past decade, NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division" are "X-Linked Hypophosphataemia" (1 trials) and "X-Linked Hypophosphatemia" (1 trials). Many other conditions were trialed in "NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division" in a lesser frequency.

The vast majority of trials in "NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".